Health-Care Crisis Topic of Debate for Hutton Ethics Lectureship
An outspoken critic of what she calls a U.S. health-care system in crisis will deliver the University of Cincinnatis (UC) 2005 Hutton Lectureship on Ethics.
Marcia Angell, MD, senior lecturer on social medicine at Harvard Medical School, will talk on "Fixing a Broken Health-Care System, from noon to 1:30 p.m. on Wednesday, Nov. 9, in the College of Medicines Kresge Auditorium, 231 Albert Sabin Way.
Dr. Angell, who argues that higher spending on health care does not necessarily prolong lives, will shed new light on the U.S. health-care system and explore the ethical concerns that play a major role in todays health-care policy debate.
More and more people are losing their health insurance, says Dr. Angell, and most of the rest of us are underinsured, in the sense that coverage is not comprehensive and we have to pay more out-of-pocket. There is plenty of money already in our system. Its just being badly spent. In order to increase coverage without increasing costs, we have to change the system altogether.
Dr. Angell is a nationally recognized authority and writer on health policy, medical ethics and medical evidence. Former editor-in-chief of the New England Journal of Medicine, Dr. Angell was named one of the 25 most influential Americans in 1997 by Time magazine. Her critically acclaimed books include Science on Trial: The Clash of Medical Evidence and the Law in the Breast Implant Case and The Truth About the Drug Companies: How They Deceive Us and What to Do About It. A graduate of Boston University School of Medicine, Dr. Angell trained in both internal medicine and anatomic pathology and is a board-certified pathologist.
UCs Hutton Lectureship on Ethics, now in its second year, is an endowed lectureship named in honor of John Hutton, MD, former dean of the UC College of Medicine. Offered once a year, the lecture focuses on current topics facing our society.
The lecture is free and open to the public, but reservations are encouraged. For more information or to register, call (513) 558-0910 or visit
.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.